Clinical Trials
4
Trial Phases
2 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Study, Evaluating Pharmacokinetics, Pharmacodynamics, Immunogenicity and Safety Profiles of Rituximab Compared to MabThera® in Patients With Rheumatoid Arthritis
- Conditions
- Rheumatoid Arthritis
- Interventions
- First Posted Date
- 2023-12-18
- Last Posted Date
- 2024-06-06
- Lead Sponsor
- Mabscale, LLC
- Target Recruit Count
- 208
- Registration Number
- NCT06175338
- Locations
- 🇷🇺
Immanuel Kant Baltic Federal University, Kaliningrad, Russian Federation
🇷🇺Scientific-Research Medical Complex Your Health, Kazan, Russian Federation
🇷🇺LLC "Medical Center Revma-Med", Kemerovo, Russian Federation
Study Evaluation of the Efficacy, Safety and Immunogenicity of Adalimumab in Comparison With Humira®
- First Posted Date
- 2023-08-22
- Last Posted Date
- 2023-11-29
- Lead Sponsor
- Mabscale, LLC
- Target Recruit Count
- 494
- Registration Number
- NCT06005532
- Locations
- 🇷🇺
Regional dermatovenerologic dispensary, Barnaul, Russian Federation
🇷🇺Chelyabinsk Regional Clinical Dermatovenerologic Dispensary, Chelyabinsk, Russian Federation
🇷🇺Interregional Clinical Diagnostic Center, Kazan', Russian Federation
Study, Evaluating Pharmacokinetics, Immunogenicity and Safety Profiles of Pertuzumab Compared to Perjeta® in Healthy Man
- First Posted Date
- 2023-04-24
- Last Posted Date
- 2024-08-16
- Lead Sponsor
- Mabscale, LLC
- Target Recruit Count
- 114
- Registration Number
- NCT05825781
- Locations
- 🇷🇺
Central Clinical Hospital "RZD-Medicina", Moscow, Russian Federation
A Safety and Efficacy Study of Bevacizumab, Paclitaxel, Carboplatin Compared to Avastin® in Non-Small Cell Lung Cancer
- Conditions
- Non-Small Cell Lung Cancer
- Interventions
- First Posted Date
- 2022-12-16
- Last Posted Date
- 2024-08-16
- Lead Sponsor
- Mabscale, LLC
- Target Recruit Count
- 620
- Registration Number
- NCT05654454
- Locations
- 🇷🇺
Arkhangelsk Clinical Oncological Dispensary, Arkhangel'sk, Russian Federation
🇷🇺State Budget Healthcare Institution Ivanovo Regional Oncology Dispensary, Ivanovo, Russian Federation
🇷🇺Kaluga Regional Clinical Oncology Dispensary, Kaluga, Russian Federation